Massive study aims to unlock secrets of rare genetic disorders
NCT ID NCT04395495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting blood, tissue, and medical information from up to 1,000 people with RASopathies—a group of genetic conditions that affect development and raise cancer risk. Researchers will store these samples and data in a database for future studies. The goal is to learn more about how these disorders work, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOFACIOCUTANEOUS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill outsmart RAS-Mutant cancers?
- Can a Triple-Drug rechallenge tame colorectal cancer?
- Can mapping rare genetic variants unlock better care for autism-related disorders?
- Light-Activated cream could slow growth of NF1 skin tumors
- Smart drug targets two cancer weaknesses at once
- New drug combo targets Hard-to-Treat cancers with RAS mutations